{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:35:21Z","timestamp":1754598921275,"version":"3.41.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Serotype-specific diagnosis of pneumococcal community-acquired pneumonia in children under age 5 years would mark a major advancement for understanding pneumococcal epidemiology and supporting vaccine decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A Luminex technology-based multiplex urinary antigen detection (UAD) diagnostic assay was developed and subsequently validated in adults, but its applicability to children is unknown. This study aimed to set appropriate cutoffs for use of the UAD in a healthy pediatric population and apply these cutoffs in children with pneumonia in sub-Saharan Africa. The cutoffs were determined by assessing 379 urines obtained from healthy children under age 5 years from the Bobo-Dioulasso area for serotypes included in 13-valent pneumococcal conjugate vaccine (UAD-1) and the 11 other serotypes unique to 23-valent pneumococcal polysaccharide vaccine (UAD-2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Based on the assigned cutoff values, among 108 children who met the World Health Organization consolidation endpoint criteria, UAD-1 and UAD-2 were positive in 23.3% and 8.3%, respectively; among 364 children with clinically suspected pneumonia who did not meet the World Health Organization criteria, UAD-1 and UAD-2 were positive for 6.6% and 3.6%, respectively. Pneumococcal carriage prevalence was similar among pneumonia cases (30%) versus controls (35%) as was semiquantitative carriage density.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>UAD-1 and UAD-2 were able to distinguish community controls from children with pneumonia, particularly pneumonia with consolidation. Future studies are needed to confirm these results and more fully assess the contribution of pneumococcal carriage and concurrent viral infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003065","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T07:07:00Z","timestamp":1610780820000},"page":"418-425","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Application of a Pneumococcal Serotype-specific Urinary Antigen Detection Test for Identification of Pediatric Pneumonia in Burkina Faso"],"prefix":"10.1097","volume":"40","author":[{"given":"Mamadou","family":"Bountogo","sequence":"first","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"},{"name":"Centre de Recherche en Sant\u00e9 de Nouna, Nouna"},{"name":"Universit\u00e9 Pr Joseph Ki-Zerbo, Ouagadougou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bintou","family":"Sanogo","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Souro Sanou, Bobo-Dioulasso, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Pride","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakari","family":"Niki\u00e8ma","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Souro Sanou, Bobo-Dioulasso, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe-Marie","family":"Njanpop-Lafourcade","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdou Salam","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Souro Sanou, Bobo-Dioulasso, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P. G.","family":"van der Linden","sequence":"additional","affiliation":[{"name":"German National Reference Center for Streptococci, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Moisi","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoua","family":"Tall","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alima","family":"Essoh","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Betsem","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9decine Pr\u00e9ventive, Abidjan, Cote d\u2019Ivoire"},{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Meda","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Pr Joseph Ki-Zerbo, Ouagadougou"},{"name":"Centre Muraz, Bobo-Dioulasso, Burkina Faso."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CVI.00064-12","article-title":"Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine.","volume":"19","author":"Pride","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00006454-200107000-00018","article-title":"Evaluation of binax now Streptococcus pneumoniae urinary antigen test in children in a community with a high carriage rate of pneumococcus.","volume":"20","author":"Adegbola","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"e52464","DOI":"10.1371\/journal.pone.0052464","article-title":"Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults.","volume":"7","author":"Mueller","year":"2012","journal-title":"PLoS One"},{"key":"R7-20250615","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies.","volume":"83","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"e0170412","DOI":"10.1371\/journal.pone.0170412","article-title":"Burden of pneumococcal disease in Northern Togo before the introduction of pneumococcal conjugate vaccine.","volume":"12","author":"Mo\u00efsi","year":"2017","journal-title":"PLoS One"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","article-title":"Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.","volume":"22","author":"O\u2019Brien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","article-title":"Qualification and clinical validation of an immunodiagnostic assay for detecting 11 additional Streptococcus pneumoniae serotype-specific polysaccharides in human urine.","volume":"71","author":"Kalina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12879-015-0788-0","article-title":"Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.","volume":"15","author":"Elberse","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JCM.01573-16","article-title":"Multiplex urinary antigen detection for 13 Streptococcus pneumoniae serotypes improves diagnosis of pneumococcal pneumonia in South African HIV-infected adults.","volume":"55","author":"Albrich","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial.","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2015.06.062","article-title":"Impact of PCV7\/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.","volume":"33","author":"Greenberg","year":"2015","journal-title":"Vaccine"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e0172690","DOI":"10.1371\/journal.pone.0172690","article-title":"Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.","volume":"12","author":"Palmu","year":"2017","journal-title":"PLoS One"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"e0224392","DOI":"10.1371\/journal.pone.0224392","article-title":"Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR.","volume":"14","author":"Dunne","year":"2019","journal-title":"PLoS One"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1038\/s41598-018-29119-w","article-title":"Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children.","volume":"8","author":"Morpeth","year":"2018","journal-title":"Sci Rep"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/infdis\/jiu326","article-title":"High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia.","volume":"210","author":"Wolter","year":"2014","journal-title":"J Infect Dis"},{"issue":"suppl_3","key":"R21-20250615","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1093\/cid\/cix100","article-title":"Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged <5 years in the PERCH Study.","volume":"64","author":"Baggett","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"(suppl 4","key":"R22-20250615","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/infdis\/jiz301","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis, Burkina Faso, 2016-2017.","volume":"220","author":"Soeters","year":"2019","journal-title":"J Infect Dis"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1016\/j.vaccine.2018.05.097","article-title":"A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.","volume":"37","author":"Gessner","year":"2019","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:05:25Z","timestamp":1750003525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003065","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2021,1,12]]}}}